Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy.

Korean J Radiol · 2019 · PMC6389804 · PMID 30799569

Europe PMC DOI

hedged sentence

0.1290

closest p · 2.6× alpha

0.1290

boldest claim

The sentences

showed a trendp = 0.129not close (p > 0.1)

In this meta-analysis, radioembolization showed a trend towards a lower incidence rate of grade 3/4 AEs than sorafenib (9% vs. 28%; p = 0.129).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.